Left ventricular mechanical and energetic changes in long-term isoproterenol-induced hypertrophied hearts of SERCA2a transgenic rats

Journal of Molecular and Cellular Cardiology

Volumn 59, Issue , 2013, Pages 95-106

  Mitsuyama, Shinichi ^a   Takeshita, Daisuke ^a   Obata, Koji ^a   Zhang, Guo Xing ^a,b   Takaki, Miyako ^a  

^a NARA MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

Author keywords

Ca2 + handling; Excitation contraction coupling; Heart failure; Oxygen consumption

Indexed keywords

ADENOSINE TRIPHOSPHATE; MITOCHONDRIAL TRANSCRIPTION FACTOR A; PHOSPHOLAMBAN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; ISOPRENALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOWN REGULATION; ECHOCARDIOGRAPHY; ENERGY TRANSFER; HEART; HEART FAILURE; HEART HYPERTROPHY; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE FIBROSIS; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE RELAXATION; MALE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTOLIC BLOOD PRESSURE; TRANSGENIC RAT; UPREGULATION; WESTERN BLOTTING; ANIMAL; CARDIOMEGALY; CHEMICALLY INDUCED DISORDER; GENETICS; METABOLISM; OXYGEN CONSUMPTION; PHYSIOLOGY;

ANIMALS; CARDIOMEGALY; ISOPROTERENOL; MALE; OXYGEN CONSUMPTION; RATS; RATS, TRANSGENIC; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

EID: 84875078681     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2013.02.012     Document Type: Article

References (32)

1. Milani, R.V., Drazner, M.H., Lavie, C.J., Morin, D.P., Ventura, H.O., Progression from concentric left ventricular hypertrophy and normal ejection fraction to left ventricular dysfunction. Am J Cardiol 108 (2011), 992–996.
2. Bers, D.M., Calcium fluxes involved in control of cardiac myocyte contraction. Circ Res 87 (2000), 275–281.
3. 2 + handling in myocardium from patients with end-stage heart failure. Circ Res 61 (1987), 70–76.
4. Arai, M., Matsui, H., Periasamy, M., Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ Res 74 (1994), 555–564.
5. 2 + transport. Circ Res 93 (2003), 487–490.
6. 2 +-ATPase gene expression in the human ventricle during end-stage heart failure. J Clin Invest 85 (1990), 305–309.
7. 2 +-ATPase increases cardiac contractility in transgenic mouse hearts. Circ Res 83 (1998), 1205–1214.
8. 2 +-ATPase in a rat model of heart failure. Circulation 104 (2001), 1424–1429.
9. 2 + transient. Circulation 96 (1997), 400–403.
10. 2 + cycling contributes to improved contractile performance in SERCA2a-overexpressing transgenic rats. Cardiovasc Res 67 (2005), 636–646.
11. Müller, O.J., Lange, M., Rattunde, H., Lorenzen, H.P., Müller, M., Frey, N., et al. Transgenic rat hearts overexpressing SERCA2a show improved contractility under baseline conditions and pressure overload. Cardiovasc Res 59 (2003), 380–389.
12. Sakata, S., Lebeche, D., Sakata, N., Sakata, Y., Chemaly, E.R., Liang, L.F., et al. Targeted gene transfer increases contractility and decreases oxygen cost of contractility in normal rat hearts. Am J Physiol Heart Circ Physiol 292 (2007), H2356–H2363.
13. Sakata, S., Lebeche, D., Sakata, Y., Sakata, N., Chemaly, E.R., Liang, L., et al. Transcoronary gene transfer of SERCA2a increases coronary blood flow and decreases cardiomyocyte size in a type 2 diabetic rat model. Am J Physiol Heart Circ Physiol 292 (2007), H1204–H1207.
14. 2 + uptake but decreases myocyte shortening. Circulation 110 (2004), 3553–3559.
15. 2 + handling in normal and diabetic rat hearts. FASEB J 16 (2002), 1657–1659.
16. Pinz, I., Tian, R., Belke, D., Swanson, E., Dillmann, W., Ingwall, J.S., Compromised myocardial energetics in hypertrophied mouse hearts diminish the beneficial effect of overexpressing SERCA2a. J Biol Chem 286 (2011), 10163–10168.
17. Vetter, R., Rehfeld, U., Reissfelder, C., Fechner, H., Seppet, E., Kreutz, R., Decreased cardiac SERCA2 expression, SR Ca uptake, and contractile function in hypothyroidism are attenuated in SERCA2 overexpressing transgenic rats. Am J Physiol Heart Circ Physiol 300 (2011), H943–H950.
18. Zhang, G.X., Obata, K., Takeshita, D., Mitsuyama, S., Nakashima, T., Kikuta, A., et al. Evaluation of left ventricular mechanical work and energetics of normal hearts in SERCA2a transgenic rats. J Physiol Sci 62 (2012), 221–231.
19. Takaki, M., Left ventricular mechanoenergetics in small animals. Jpn J Physiol 54 (2004), 175–207.
20. Takeshita, D., Shimizu, J., Kitagawa, Y., Yamashita, D., Tohne, K., Nakajima-Takenaka, C., et al. Isoproterenol-induced hypertrophied rat hearts: does short-term treatment correspond to long-term treatment?. J Physiol Sci 58 (2008), 179–188.
21. Nakajima-Takenaka, C., Zhang, G.X., Obata, K., Tohne, K., Matsuyoshi, H., Nagai, Y., et al. Left ventricular function of isoproterenol-induced hypertrophied rat hearts perfused with blood: mechanical work and energetics. Am J Physiol Heart Circ Physiol 297 (2009), H1736–H1743.
22. Watanabe, A., Arai, M., Koitabashi, N., Niwano, K., Ohyama, Y., Yamada, Y., et al. Mitochondrial transcription factors TFAM and TFB2M regulate Serca2 gene transcription. Cardiovasc Res 90 (2011), 57–67.
23. Shibata, M., Takeshita, D., Obata, K., Mitsuyama, S., Ito, H., Zhang, G.X., et al. NHE-1 participates in isoproterenol-induced downregulation of SERCA2a and development of cardiac remodeling in rat hearts. Am J Physiol Heart Circ Physiol 301 (2011), H2154–H2160.
24. Yoshikawa, Y., Zhang, G.X., Obata, K., Ohga, Y., Matsuyoshi, H., Taniguchi, S., et al. Cardioprotective effects of a novel calpain inhibitor SNJ-1945 for reperfusion injury after cardioplegic cardiac arrest. Am J Physiol Heart Circ Physiol 298 (2010), H643–H651.
25. 2 use-pressure–volume area relation from curved end-systolic pressure–volume relation of the blood-perfused rat left ventricle. Jpn J Physiol 48 (1998), 197–204.
26. Tsuji, T., Ohga, Y., Yoshikawa, Y., Sakata, S., Kohzuki, H., Misawa, H., et al. New index for oxygen cost of contractility from curved end-systolic pressure–volume relations in cross-circulated rat hearts. Jpn J Physiol 49 (1999), 513–520.
27. Sakata, S., Ohga, Y., Abe, T., Tabayashi, N., Kobayashi, S., Tsuji, T., et al. No dependency of a new index for oxygen cost of left ventricular contractility on heart rates in the blood-perfused excised rat heart. Jpn J Physiol 51 (2001), 177–185.
28. Matsubara, H., Araki, J., Takaki, M., Nakagawa, S.T., Suga, H., Logistic characterization of left ventricular isovolumic pressure–time curve. Jpn J Physiol 45 (1995), 535–552.
29. Matsubara, H., Takaki, M., Yasuhara, S., Araki, J., Suga, H., Logistic time constant of isovolumic relaxation pressure–time curve in the canine left ventricle. Better alternative to exponential time constant. Circulation 92 (1995), 2318–2326.
30. Niwano, K., Arai, M., Koitabashi, N., Watanabe, A., Ikeda, Y., Miyoshi, H., et al. Lentiviral vector-mediated SERCA2 gene transfer protects against heart failure and left ventricular remodeling after myocardial infarction in rats. Mol Ther 16 (2008), 1026–1032.
31. Huke, S., Prasad, V., Nieman, M.L., Nattamai, K.J., Grupp, I.L., Lorenz, J.N., et al. Altered dose response to β-agonists in SERCA1-expressing hearts ex vivo and in vivo. Am J Physiol Heart Circ Physiol 283 (2002), H958–H966.
32. O'Donnell, J.M., Fields, A., Xu, X., Chowdhury, S.A., Geenen, D.L., Bi, J., Limited functional and metabolic improvements in hypertrophic and healthy hearts expressing the skeletal muscle isoform of SERCA1 by adenoviral gene transfer in vivo. Am J Physiol Heart Circ Physiol 295 (2008), H2483–H2494.